同仁堂：公司产品苏合香丸获得加拿大产品许可证

Core Viewpoint - Tong Ren Tang's product Su He Xiang Wan has received a product license from Health Canada, marking a significant step towards potential sales in Canada, although further administrative approvals are required [1] Group 1 - The company announced that its subsidiary, Tong Ren Tang Pharmaceutical Factory, has been granted a Class III product license for Su He Xiang Wan by Health Canada [1] - The product must still undergo additional administrative approvals, including Canadian production quality system certification, before it can be sold in Canada [1] - The recent approval is not expected to have a significant impact on the company's short-term operating performance [1]